Neuropathic Pain
1 competing product in clinical development for Neuropathic Pain.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| OK-101 0.05% + OK-101 0.1% + Placebo | OKYO Pharma | Phase 2 | Terminated | 44 |
1 competing product in clinical development for Neuropathic Pain.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| OK-101 0.05% + OK-101 0.1% + Placebo | OKYO Pharma | Phase 2 | Terminated | 44 |